ArrowMark Partners is a $24.6 billion asset management firm located in Denver, Colorado. ArrowMark was founded on the belief that superior asset management is derived from the synthesis of Experience, Research and Partnership.
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 07.02.2026 | Skyryse | skyryse.com | $638M | United Sta... |
| 14.02.2023 | Checkerspo... | checkerspot.com | $109M | United Sta... |
Mentions in press and media 12
| Date | Title | Description |
| 04.03.2026 | Poplar Therapeutics Raises $45M in Series A Extension Funding | Poplar Therapeutics, a Cambridge, MA-based clinical-stage immunology company, raised $45M in Series A extension funding. The round was led by Janus Henderson Investors, with participation from RA Capital, SR One, Vida Ventures and affiliate... |
| 03.03.2026 | Poplar Therapeutics: $45 Million Series A Extension Raised By Immunology Company To Advance Anti-IgE Therapy PHB-050 | Poplar Therapeutics, a clinical-stage immunology company developing a new class of anti-IgE therapy for food allergy and other atopic conditions, has closed a $45 million Series A extension, bringing its total Series A financing to $95 mill... |
| 07.02.2026 | Skyryse: $300+ Million Series C Raised At $1.15 Billion Valuation For Aviation Automation | Skyryse, an aviation automation company focused on simplified flight controls, said it raised more than $300 million in a Series C round, valuing the business at more than $1.15 billion. The company said it has now raised more than $605 mil... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood tests | The San Francisco company readies to reveal its first clinical study results in the near term When it comes to cancer, spotting it early can make a big difference on treatment options and survival. Commonly a progressive disease, certain un... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance their blood-based cancer detection tests. The investment, led by Roche and backed by a slew of other big names, will propel Freenome's mission ... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection Platform | What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti... |
| 25.05.2023 | ArrowMark Partners’ Closes Fourth Fund Vintage Dedicated to Regulatory Capital Relief Investments with $1.1 Billion in Commitments | - |
| 09.11.2021 | StoneCastle Financial Corp. (BANX) Announces Participation in the Q4 Virtual Investor Summit | Denver, Colorado--(Newsfile Corp. - November 9, 2021) - StoneCastle Financial Corp. (NASDAQ: BANX) today announced that Sanjai Bhonsle, CEO & Patrick Farrell, CFO will be attending the Q4 Virtual Investor Summit. During the presentation... |
| 03.01.2018 | Centrexion’s $67M Series D round to fund Phase 3 pain studies | Despite being just four years old, Centrexion is building a significant pipeline of non-opioid, non-steroidal pain medications. CNTX-4975 is being developed to treat pain from osteoarthritis and Morton’s Neuroma. The drug is a synthetic tra... |
| 07.11.2017 | Intersection raises $150 million for the global expansion of its free Wi-Fi | As it looks to expand the global footprint of its internet-enabled digital advertising and informational kiosks, New York-based Intersection has raised $150 million in a new round of financing. The company has installed hundreds of its obel... |
Show more